Cargando…
Specifically differentiated T cell subset promotes tumor immunity over fatal immunity
Allogeneic immune cells, particularly T cells in donor grafts, recognize and eliminate leukemic cells via graft-versus-leukemia (GVL) reactivity, and transfer of these cells is often used for high-risk hematological malignancies, including acute myeloid leukemia. Unfortunately, these cells also atta...
Autores principales: | Ramadan, Abdulraouf, Griesenauer, Brad, Adom, Djamilatou, Kapur, Reuben, Hanenberg, Helmut, Liu, Chen, Kaplan, Mark H., Paczesny, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716032/ https://www.ncbi.nlm.nih.gov/pubmed/29038366 http://dx.doi.org/10.1084/jem.20170041 |
Ejemplares similares
-
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
por: Griesenauer, Brad, et al.
Publicado: (2017) -
Editorial: Danger Signals Triggering Immune Response and Inflammation
por: Ramadan, Abdulraouf, et al.
Publicado: (2017) -
Biomarkers for Allogeneic HCT Outcomes
por: Adom, Djamilatou, et al.
Publicado: (2020) -
Less cholesterol means better tumor killing for cytotoxic T9 cells
por: Griesenauer, Brad, et al.
Publicado: (2018) -
Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation
por: Ramadan, Abdulraouf, et al.
Publicado: (2015)